UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Discovery of 5-(2-chloro-4′-(1H-imidazol-1-yl)-[1,1′-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD

Bioorganic & medicinal chemistry letters, 2018-12, Vol.28 (23-24), p.3766-3773

2018

Link zum Volltext

Verfügbarkeit prüfen

Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2

Bioorganic & medicinal chemistry letters, 2018-04, Vol.28 (7), p.1211-1218

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1

Bioorganic & medicinal chemistry letters, 2017-12, Vol.27 (23), p.5131-5138

2017

Link zum Volltext

Verfügbarkeit prüfen

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2594-2601

2017

Link zum Volltext

Verfügbarkeit prüfen

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2594-2601

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor

Bioorganic & medicinal chemistry letters, 2016-12, Vol.26 (24), p.5977-5984

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and Characterization of an Avirulent Leishmania major Strain

The Journal of immunology (1950), 2020-05, Vol.204 (10), p.2734-2753

2020

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani

Cytokine (Philadelphia, Pa.), 2024-02, Vol.174, p.156475-156475, Article 156475

2024

Link zum Volltext

Verfügbarkeit prüfen

Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection

International immunopharmacology, 2024-03, Vol.129, p.111589-111589, Article 111589

2024

Link zum Volltext

Verfügbarkeit prüfen

Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection

International immunopharmacology, 2024-06, Vol.134, p.112100, Article 112100

2024

Link zum Volltext

Verfügbarkeit prüfen

Hyperaggregation of platelets in intestinal tuberculosis: Role of platelets in chronic inflammation

American journal of hematology, 1995-01, Vol.48 (1), p.52-54

1995

Link zum Volltext

Verfügbarkeit prüfen

Response: Philadelphia chromosome excludes the diagnosis of essential thrombocythemia

American journal of hematology, 1990-09, Vol.35 (1), p.72-72

1990

Link zum Volltext

Verfügbarkeit prüfen

Dysmyelopoietic Features and Bone Marrow Histology in 30 Cases of Primary Myelodysplastic Syndromes

Leukemia & lymphoma, 1991, Vol.3 (5-6), p.419-422

1991

Link zum Volltext

Verfügbarkeit prüfen

Haemostatic derangement in patients with intracranial tumours

British journal of neurosurgery, 1994, Vol.8 (6), p.695-702

1994

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous occurrence of factor VIIIC inhibitor and antinuclear antibody in postpartum period

American journal of hematology, 1991-05, Vol.37 (1), p.49-50

1991

Link zum Volltext

Verfügbarkeit prüfen

A case of erythroleukaemia with partial expression of fetal red cell markers

Journal of the Association of Physicians of India, 1988-10, Vol.36 (10), p.620

1988

Link zum Volltext

Verfügbarkeit prüfen

Time dependent factor IX inhibitor

Thrombosis and haemostasis, 1989, Vol.62 (4), p.1151

1989

Link zum Volltext

Verfügbarkeit prüfen

Can rifampicin be restarted in patients with rifampicin-induced thrombocytopenia?

Tubercle, 1991-12, Vol.72 (4), p.306-307

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Discovery of 5-(2-chloro-4′-(1H-imidazol-1-yl)-[1,1′-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD

Alleviating CYP and hERG liabilities by structure optimization of dihydrofuran-fused tricyclic benzo[d]imidazole series – Potent, selective and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-2

Discovery of furan and dihydrofuran-fused tricyclic benzo[d]imidazole derivatives as potent and orally efficacious microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors: Part-1

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model

Tricyclic 4,4-dimethyl-3,4-dihydrochromeno[3,4-d]imidazole derivatives as microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors: SAR and in vivo efficacy in hyperalgesia pain model

Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitor

Discovery of 2-((2-chloro-6-fluorophenyl)amino)- N -(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1 H -[1,4]dioxino[2′,3′:3,4]benzo[1,2- d ]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E 2 synthase-1 (mPGES-1) inhibitor

Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2′,3′:3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor

Development and Characterization of an Avirulent Leishmania major Strain

Interleukin-7 potentiates MAPK10-elicited host-protective vaccine against Leishmania donovani

Myotubularin-related protein-6 silencing protects mice from Leishmania donovani infection

Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection

Hyperaggregation of platelets in intestinal tuberculosis: Role of platelets in chronic inflammation

Response: Philadelphia chromosome excludes the diagnosis of essential thrombocythemia

Dysmyelopoietic Features and Bone Marrow Histology in 30 Cases of Primary Myelodysplastic Syndromes

Haemostatic derangement in patients with intracranial tumours

Simultaneous occurrence of factor VIIIC inhibitor and antinuclear antibody in postpartum period

A case of erythroleukaemia with partial expression of fetal red cell markers

Time dependent factor IX inhibitor

Can rifampicin be restarted in patients with rifampicin-induced thrombocytopenia?

Suchergebnisse filtern